Baltimore, MD, United States of America

Yuguo Li

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuguo Li: Innovator in Tissue Vascular Permeability Assessment

Introduction

Yuguo Li is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of biomedical engineering, particularly in assessing tissue vascular permeability. His innovative approach utilizes non-labeled dextran, which has implications for nanotherapeutics.

Latest Patents

Yuguo Li holds a patent titled "Methods and systems of assessing tissue vascular permeability using non-labeled dextran." This patent describes a method for evaluating tissue vascular permeability by receiving a non-labeled, physiologically-tolerable dextran solution from a subject. The process involves acquiring multiple magnetic resonance images of the dextran solution's distribution within a region of interest over time. The assessment of tissue vascular permeability is based on the differences observed in these images, utilizing a substantially mono-disperse solution of dextran particles of one size. He has 1 patent to his name.

Career Highlights

Throughout his career, Yuguo Li has worked with prestigious institutions, including The Johns Hopkins University and Kennedy Krieger Institute, Inc. His work has been instrumental in advancing the understanding of tissue vascular permeability, which is crucial for the development of effective nanotherapeutics.

Collaborations

Yuguo Li has collaborated with esteemed colleagues such as Guanshu Liu and Peter C M Van Zijl. These collaborations have further enriched his research and contributed to the advancements in his field.

Conclusion

Yuguo Li's innovative work in assessing tissue vascular permeability using non-labeled dextran showcases his commitment to advancing biomedical engineering. His contributions are paving the way for future developments in nanotherapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…